Skip to content

A Eye Movement Desensitization Reprocessing (EMDR) Study in Bipolar Traumatized Patients

A Controlled, Single-blind Pilot Study of EMDR in Bipolar, Subsyndromal Patients With Trauma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01620866
Acronym
BET
Enrollment
20
Registered
2012-06-15
Start date
2010-11-30
Completion date
2012-06-30
Last updated
2012-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, PTSD

Keywords

EMDR, bipolar disorder, trauma, subsyndromal symptoms, PTSD

Brief summary

The purpose of this pilot study is whether Eye Movement Desensitization Reprocessing (EMDR), an approved psychotherapy in posttraumatic stress disorder, improves mood, functioning, quality of life, cognition and BDNF levels in subsyndromal bipolar patients with trauma.

Interventions

EMDR is an effective treatment in PTSD but has never been tested in bipolar traumatized patients.

Sponsors

FIDMAG Germanes Hospitalàries
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Bipolar I or II disorder following DSM-IV criteria * Instable, subsyndromal course defined as at evaluation baseline (HAMD \> 8 \< 15 and/or YMRS \> 7 \< 14) * Good adherence to pharmacological treatment * Major or minor traumatic life-events * EMDR therapists \> 3 years experience * Able to sign informed consent

Exclusion criteria

* Major affective episode in last 3 months * Active drug abuse/dependency * Neurological disease * Suicidal thoughts/ideation * Prior treatment EMDR * DES \> 25

Design outcomes

Primary

MeasureTime frameDescription
The primary outcome of this study is a statistically significant reduction in the YMRS and/or HDRS in the EMDR group compared with the TAU group.3 months and 6 monthsPatients with subsydromal symptoms, objectified by the YMRS and HDRS, are included in the study. After randomization to EMDR or TAU, group differences in changes in the YMRS and HRDS are measured at visit after intervention (3 months) and at follow-up (6 months). The hypothesize is that the EMDR group will statistically improve in both affective scales when compared to the TAU group.

Secondary

MeasureTime frameDescription
The EMDR group improves statistically significant in trauma load when compared to TAU.3 months and 6 monthsSecondary outcome measure includes changes in trauma scales (IES, CAPS)from baseline to 3 months and 6 months.
The EMDR group improves statistically significant in cognitive tests when compared to TAU.3 months and 6 monthsSubjects underwent a neuropsychologcial battery to test various cognitive domains.
The EMDR group improves statistically significant in functioning when compared to TAU.3 months and 6 monthsAll subjects were evaluated with respect to their functioning using the FAST, a validated scale of functioning in bipolar disorder.
The EMDR group improves statistically significant in quality of life when compared to TAU.3 months and 6 monthsPossible changes of Quality of life were tested in all subjects as well, using the SF-36.
Plasma levels of BDNF was statistically higher in the EMDR group after intervention when compared to TAU.3 months and 6 monthsLevels of BDNF are lower in bipolar patients, and even lower when traumatized, when compared to the general population. We aimed to find higher levels of BDNF in the EMDR group.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026